Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical research collaboration
Biotech
GSK still has a crush on oligonucleotides, seals deal with Elsie
Before being swayed by ADCs, one of GSK’s passion projects was oligonucleotides. A new opt-in suggests the British Pharma is still smitten.
James Waldron
Feb 14, 2024 9:45am
RetinAI Medical joins non-profit macular degeneration initiative
Nov 29, 2023 11:36am
BMS, Avidity add another $100M to cardiovascular partnership
Nov 28, 2023 6:30am
NASA, Defender to test motion sickness gel for astronauts
Nov 1, 2023 9:00am
Intellia, Regeneron to take CRISPR collab outside the liver
Oct 3, 2023 9:40am
With $1.7B Immatics deal, Moderna bets again on cancer vaccines
Sep 11, 2023 8:12am